Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
4.770
+0.940 (24.54%)
At close: Mar 27, 2026, 4:00 PM EDT
5.05
+0.28 (5.87%)
After-hours: Mar 27, 2026, 7:59 PM EDT

Quantum BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
27297363042
Market Cap Growth
224.59%321.68%-80.54%20.93%-29.85%40.95%
Enterprise Value
253003263
Last Close Price
4.777.303.6859.7951.2566.30
PB Ratio
5.315.760.672.770.970.78
P/TBV Ratio
11.2312.181.064.541.601.11
Debt / Equity Ratio
0.370.370.080.030.020.01
Net Debt / Equity Ratio
-0.10-0.10-0.61-0.25-0.54-0.64
Net Debt / EBITDA Ratio
0.030.030.410.190.721.17
Net Debt / FCF Ratio
0.060.060.930.290.581.68
Quick Ratio
0.430.431.652.392.224.13
Current Ratio
1.071.071.812.432.285.28
Return on Equity (ROE)
-346.87%-346.87%-127.76%-83.91%-63.08%-75.05%
Return on Assets (ROA)
-67.64%-67.64%-58.31%-43.02%-33.82%-40.20%
Return on Capital Employed (ROCE)
-299.90%-299.90%-154.60%-149.00%-89.70%-62.20%
Earnings Yield
-96.67%-89.14%-203.95%-50.03%-79.79%-83.66%
FCF Yield
-30.42%-28.05%-98.75%-30.26%-96.15%-49.19%
Buyback Yield / Dilution
-189.01%-189.01%-86.67%-2.21%-10.84%-190.15%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q